Top News

• Keep GLP-1s Off Bulks List: FDA
• House Committee Advances FDA Funding Bill Amid Policy Disputes
• Nubeqa TV Ad, Video Misleading: FDA
• FDA Panel Rejects Astrazenecas Camizestrant In Closely Watched Vote
• Enrollment Halted in Newrons Schizophrenia Study After Patient Death
• Eugia Pharma Specialties FDA-483 Out
• Using AI in Drug Development
• 1st Non-Antipsychotic OKd for Agitation in Alzheimers Patients